- Home
- CCCC vs TWIN Comparison
CCCC vs TWIN Comparison
Compare CCCC & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- TWIN
- Stock Information
- Founded
- CCCC 2015
- TWIN 1918
- Country
- CCCC United States
- TWIN United States
- Employees
- CCCC N/A
- TWIN N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- TWIN Industrial Machinery/Components
- Sector
- CCCC Health Care
- TWIN Industrials
- Exchange
- CCCC Nasdaq
- TWIN Nasdaq
- Market Cap
- CCCC 175.1M
- TWIN 186.2M
- IPO Year
- CCCC 2020
- TWIN N/A
- Fundamental
- Price
- CCCC $2.23
- TWIN $14.12
- Analyst Decision
- CCCC Strong Buy
- TWIN Strong Buy
- Analyst Count
- CCCC 4
- TWIN 1
- Target Price
- CCCC $8.50
- TWIN $12.00
- AVG Volume (30 Days)
- CCCC 1.8M
- TWIN 42.5K
- Earning Date
- CCCC 10-30-2025
- TWIN 11-05-2025
- Dividend Yield
- CCCC N/A
- TWIN 1.14%
- EPS Growth
- CCCC N/A
- TWIN N/A
- EPS
- CCCC N/A
- TWIN N/A
- Revenue
- CCCC $34,240,000.00
- TWIN $340,738,000.00
- Revenue This Year
- CCCC N/A
- TWIN $10.79
- Revenue Next Year
- CCCC N/A
- TWIN $8.43
- P/E Ratio
- CCCC N/A
- TWIN N/A
- Revenue Growth
- CCCC 16.55
- TWIN 15.46
- 52 Week Low
- CCCC $1.09
- TWIN $6.16
- 52 Week High
- CCCC $7.14
- TWIN $14.93
- Technical
- Relative Strength Index (RSI)
- CCCC 38.70
- TWIN 64.67
- Support Level
- CCCC $2.13
- TWIN $13.06
- Resistance Level
- CCCC $3.43
- TWIN $14.93
- Average True Range (ATR)
- CCCC 0.30
- TWIN 0.70
- MACD
- CCCC -0.12
- TWIN -0.09
- Stochastic Oscillator
- CCCC 6.58
- TWIN 62.15
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.